Why is your hip sore, and what can help?

What can you do when the hip first acts up?

Keep the hip moving gently, but shorten anything that makes it hurt more. You may do better with brief walks spaced through the day. Using a cane shifts part of your weight away from the aching hip. Don't keep going once your steps become uneven or the ache keeps rising.

Warmth before a walk can loosen stiffness, while cold may soothe soreness later. Use whichever feels better, and place cloth between your skin and the hot or cold pack. Check with a pharmacist or your doctor before taking a pain pill because some choices can harm the stomach, kidneys, or heart.

When is the soreness worth an exam?

Book an exam once soreness changes your walk, sleep, or usual chores. Point to the starting spot and show which movement brings it on, so the exam can focus on hip movement, leg strength, and sore areas. An X-ray can reveal a break or wear within the hip joint.

After a fall, seek urgent help if the sore leg won't hold you. Warmth and swelling near the hip with fever also calls for quick medical care. Call for emergency help when leg weakness or numbness appears with new trouble controlling urine or bowel movements. Use emergency care rather than a regular appointment for those problems.

What if the soreness doesn't settle?

For joint soreness, QC Kinetix offers a visit to discuss non-surgical regenerative treatments, meaning office procedures such as PRP. Clinics call that option PRP, short for platelet-rich plasma. The clinic makes it by spinning your blood so the part used for the procedure holds more platelets. A licensed medical provider at the clinic performs each procedure.

Ask who will do yours and why it may fit your hip. Natural pain treatments and joint preservation mean trying to ease soreness without replacing the joint. They may be discussed as hip surgery alternatives, but they don't prove cartilage will grow back.

Knee results can't tell you how a hip will respond, so find out what the clinic will use and what relief may be possible. Get the full cost, risks, and later care in writing. You'll then have clear facts to discuss with your own doctor.

Sources

1. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.

2. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit.

   Awad G, et al. — Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.. Clinical rheumatology, 2026. DOI: 10.1007/s10067-026-08042-w.

3. A dual systematic review compared the RCT evidence on injectable orthobiologics for knee OA with how news media describe it. Of 14 qualifying RCTs, 8 showed significant pain improvement and 10 function improvement, with frequent heterogeneity and risk of bias. Of 124 news articles: 79.0% highlighted benefits, only 29.8% mentioned drawbacks, 37.1% used the term 'stem cell' without specifying the product, 35.5% mentioned commercial entities with no disclosure, and 66.1% were favourable in tone. The authors conclude this disconnect encourages unrealistic expectations.

   Zhang EJX, et al. — Disparities in Evidence and Media Portrayal of Injectable Orthobiologics for Knee Osteoarthritis: A Systematic Review of Randomized Trials and News Media.. Orthopaedic journal of sports medicine, 2026. DOI: 10.1177/23259671261443876.

4. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.

5. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo.

   Gazendam A, et al. — Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.. British Journal of Sports Medicine, 2021. DOI: 10.1136/bjsports-2020-102179.